Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BODY & MIND INC.BAMM · Entity 94317 | Director · 10% owner | April 25, 2023 | April 28, 2023 |
| Grown Rogue International Inc.GRUSF · Entity 6710 | 10% owner | April 08, 2022 | April 07, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BODY & MIND INC.
Report date April 25, 2023 · Filed April 28, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.07 · Expires 2028-04-25 | Direct | 250,000 |
Reported balance
After 2023-04-25 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2023-04-25 · Grant · Acquired 250,000 · Balance 250,000 F1: Prices shown reflect Canadian dollars. F2: Granted pursuant to and in accordance with the Company stock incentive plan. F3: The Options become exercisable as to 62,500 Options on October 25, 2023, 62,500 Options on April 25, 2024, 62,500 Options on October 25, 2024 and 62,500 Options on April 25, 2025. |
Filing footnotes · ownership attribution and instrument terms
F1: Prices shown reflect Canadian dollars.
F2: Granted pursuant to and in accordance with the Company stock incentive plan.
F3: The Options become exercisable as to 62,500 Options on October 25, 2023, 62,500 Options on April 25, 2024, 62,500 Options on October 25, 2024 and 62,500 Options on April 25, 2025.
Grown Rogue International Inc.
Report date April 08, 2022 · Filed April 07, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectSee Footnote | 24,365,000 |
Reported balance
Holding disclosure · report date 2022-04-08 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 24,365,000 F1: On April 8, 2022 Bengal Catalyst Fund LP (the "Fund") made open market purchases of 200,000 shares of common stock of the issuer ("Shares"), resulting in the fund owning 17,120,000 shares or approximately 10.03% of the outstanding Shares. Subsequently, between April 11 and October 13, 2022, the Fund made open market purchases of 7,245,000 Shares. Bengal Impact Partners, LLC ("Manager") manages the Fund, and may be deemed to beneficially own the 24,365,000 Shares held by the Fund. Joshua Rosen shares investment control and voting power over the Manager with Sanjay Tolia, and as such, may be deemed to beneficially own the 24,365,000 Shares held by the Fund. Each of the Manager and Mr. Rosen disclaims beneficial ownership of the Shares held by the Fund reported herein, except to the extent of its or his respective pecuniary interest therein. |
Filing footnotes · ownership attribution and instrument terms
F1: On April 8, 2022 Bengal Catalyst Fund LP (the "Fund") made open market purchases of 200,000 shares of common stock of the issuer ("Shares"), resulting in the fund owning 17,120,000 shares or approximately 10.03% of the outstanding Shares. Subsequently, between April 11 and October 13, 2022, the Fund made open market purchases of 7,245,000 Shares. Bengal Impact Partners, LLC ("Manager") manages the Fund, and may be deemed to beneficially own the 24,365,000 Shares held by the Fund. Joshua Rosen shares investment control and voting power over the Manager with Sanjay Tolia, and as such, may be deemed to beneficially own the 24,365,000 Shares held by the Fund. Each of the Manager and Mr. Rosen disclaims beneficial ownership of the Shares held by the Fund reported herein, except to the extent of its or his respective pecuniary interest therein.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Vireo Growth Inc.
Report date August 23, 2024 · Filed February 25, 2025
Section 16 reporting ended · disclosed 2025-02-25. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.47 · Expires 2034-08-22 | Direct | 160,162 |
Reported balance
After 2024-08-23 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2024-08-23 · Grant · Acquired 160,162 · Balance 160,162 |
| Restricted stock unitsSEC Table II · derivative / convertible security | Direct | 134,195 |
Reported balance
After 2024-08-23 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2024-08-23 · Grant · Acquired 134,195 · Balance 134,195 F1: Each restricted stock unit ("RSU") represents a contingent right to receive one subordinate voting share. F2: RSUs vested immediately. Vested RSUs settle in cash or shares on (a) the third anniversary of the grant date; (b) on the death or permanent disability of the reporting person; (c) upon a change in control of the company; or (d) 18 months after the separation of service of the reporting person with or without cause. |
| Restricted stock unitsSEC Table II · derivative / convertible security | Direct | 216,450 |
Reported balance
After 2024-08-23 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2024-08-23 · Grant · Acquired 216,450 · Balance 216,450 F1: Each restricted stock unit ("RSU") represents a contingent right to receive one subordinate voting share. F3: RSUs vest in full on the first to occur of (a) December 31, 2026; (b) termination of the reporting person other than for cause; or (c) resignation of the reporting person for good reason. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit ("RSU") represents a contingent right to receive one subordinate voting share.
F2: RSUs vested immediately. Vested RSUs settle in cash or shares on (a) the third anniversary of the grant date; (b) on the death or permanent disability of the reporting person; (c) upon a change in control of the company; or (d) 18 months after the separation of service of the reporting person with or without cause.
F3: RSUs vest in full on the first to occur of (a) December 31, 2026; (b) termination of the reporting person other than for cause; or (c) resignation of the reporting person for good reason.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 10, 2024 Filed Oct 11, 2024 16:26 UTC | Vireo Growth Inc. VREOF · Entity 5397 | GrantSubordinate Voting Shares | 500,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-108059 · tm2426040-1_4seq1.xml · nonDerivative · entry 1 Rosen Joshua · CIK 0001880089 · Director · CEO and Interim CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 500,000 F1 · shares: Represents subordinate voting shares underlying restricted stock units ("RSUs") granted to Mr. Rosen in connection with his Separation Agreement with the Company. The RSUs are granted under the Vireo Health International Inc. 2019 Equity Incentive Plan, as amended, and vest in 12 equal installments commencing January 1, 2025 and ending on December 1, 2025. Read SEC document |
| October 09, 2024 Filed Oct 11, 2024 16:26 UTC | Vireo Growth Inc. VREOF · Entity 5397 | GrantStock Option (right to buy) · Derivative | 500,000 | $0.00 Strike: $0.50 | $0.00 |
DisclosureSEC source: 0001104659-24-108059 · tm2426040-1_4seq1.xml · derivative · entry 4 Rosen Joshua · CIK 0001880089 · Director · CEO and Interim CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 500,000 Underlying: Subordinate Voting Shares · 500,000 shares Expires 2027-10-09 Read SEC document |
| August 23, 2024 Filed Oct 11, 2024 16:26 UTC | Vireo Growth Inc. VREOF · Entity 5397 | GrantStock Option (right to buy) · Derivative | 250,000 | $0.00 Strike: $0.47 | $0.00 |
DisclosureSEC source: 0001104659-24-108059 · tm2426040-1_4seq1.xml · derivative · entry 3 Rosen Joshua · CIK 0001880089 · Director · CEO and Interim CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 250,000 Underlying: Subordinate Voting Shares · 250,000 shares Expires 2034-08-22 F3 · derivative.exercise_date: Vests in tranches of 62,500 options upon the first, second, third and fourth anniversary dates following the grant date. Read SEC document |
| August 23, 2024 Filed Feb 25, 2025 16:07 UTC | Vireo Growth Inc. VREOF · Entity 5397 | GrantRestricted stock units · Derivative | 216,450 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-016932 · tm257520-4_4seq1.xml · derivative · entry 3 Rosen Joshua · CIK 0001880089 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 216,450 Underlying: Subordinate voting shares · 216,450 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one subordinate voting share. F3 · derivative.exercise_date: RSUs vest in full on the first to occur of (a) December 31, 2026; (b) termination of the reporting person other than for cause; or (c) resignation of the reporting person for good reason. F3 · derivative.expiration_date: RSUs vest in full on the first to occur of (a) December 31, 2026; (b) termination of the reporting person other than for cause; or (c) resignation of the reporting person for good reason. Read SEC document |
| August 23, 2024 Filed Feb 25, 2025 16:07 UTC | Vireo Growth Inc. VREOF · Entity 5397 | GrantRestricted stock units · Derivative | 134,195 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-016932 · tm257520-4_4seq1.xml · derivative · entry 2 Rosen Joshua · CIK 0001880089 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 134,195 Underlying: Subordinate voting shares · 134,195 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one subordinate voting share. F2 · derivative.exercise_date: RSUs vested immediately. Vested RSUs settle in cash or shares on (a) the third anniversary of the grant date; (b) on the death or permanent disability of the reporting person; (c) upon a change in control of the company; or (d) 18 months after the separation of service of the reporting person with or without cause. F2 · derivative.expiration_date: RSUs vested immediately. Vested RSUs settle in cash or shares on (a) the third anniversary of the grant date; (b) on the death or permanent disability of the reporting person; (c) upon a change in control of the company; or (d) 18 months after the separation of service of the reporting person with or without cause. Read SEC document |
| August 23, 2024 Filed Feb 25, 2025 16:07 UTC | Vireo Growth Inc. VREOF · Entity 5397 | GrantStock Option (right to buy) · Derivative | 160,162 | $0.00 Strike: $0.47 | $0.00 |
DisclosureSEC source: 0001104659-25-016932 · tm257520-4_4seq1.xml · derivative · entry 1 Rosen Joshua · CIK 0001880089 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 160,162 Underlying: Subordinate Voting Shares · 160,162 shares Expires 2034-08-22 Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 19:04 UTC | Vireo Growth Inc. GDNSF · Entity 5397 | GrantSubordinate Voting Shares | 121,625 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-068371 · tm2416436-1_4seq1.xml · nonDerivative · entry 1 Rosen Joshua · CIK 0001880089 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 204,462 F1 · shares: Represents subordinate voting shares underlying restricted stock units ("RSUs") granted to Mr. Rosen for the quarter ended March 31, 2024 that were approved in connection with the execution of Mr. Rosen's employment agreement on May 1, 2024. Mr. Rosen receives quarterly awards of RSUs representing shares of the Company's Subordinate Voting Shares pursuant to his employment agreement with the Company. The RSUs are granted under the Vireo Health International Inc. 2019 Equity Incentive Plan, as amended, and become vested upon the first to occur of (a) December 31, 2026 (subject to Mr. Rosen's continued employment through that date), (b) termination of Mr. Rosen's employment other than for Cause (as defined in the Rosen Employment Agreement) or (c) Mr. Rosen's resignation from employment for Good Reason (as defined in the Rosen Employment Agreement). Read SEC document |
| April 25, 2023 Filed Apr 28, 2023 17:36 UTC | BODY & MIND INC. BAMM · Entity 94317 | GrantOptions (right to buy) · Derivative | 250,000 | $0.00 Strike: $0.07 | $0.00 |
DisclosureSEC source: 0001104659-23-053208 · tm2314144-1_4seq1.xml · derivative · entry 1 Rosen Joshua · CIK 0001880089 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 250,000 Underlying: Common Stock · 250,000 shares Expires 2028-04-25 F1 · derivative.exercise_price: Prices shown reflect Canadian dollars. F2 · kind: Granted pursuant to and in accordance with the Company stock incentive plan. F3 · derivative.exercise_date: The Options become exercisable as to 62,500 Options on October 25, 2023, 62,500 Options on April 25, 2024, 62,500 Options on October 25, 2024 and 62,500 Options on April 25, 2025. Read SEC document |
| December 14, 2022 Filed Jan 9, 2023 17:05 UTC | Vireo Growth Inc. GDNSF · Entity 5397 | GrantStock Options · Derivative | 2,000,000 | $0.30 Strike: $0.30 | $600,000.00 |
DisclosureSEC source: 0001415889-23-000695 · form4-01092023_050101.xml · derivative · entry 4 Rosen Joshua · CIK 0001880089 · Director · INTERIM PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,119,453 Underlying: Subordinate Voting Shares · 2,000,000 shares Expires 2032-12-14 F1 · derivative.exercise_date: Stock Options are vested 1/4 upon grant, 1/4 on March 1, 2023, 1/4 on June 1, 2023 and 1/4 on October 1, 2023 and are subject to vesting conditions. Read SEC document |
| December 14, 2022 Filed Jan 9, 2023 17:05 UTC | Vireo Growth Inc. GDNSF · Entity 5397 | GrantStock Options · Derivative | 79,468 | $0.30 Strike: $0.30 | $23,840.40 |
DisclosureSEC source: 0001415889-23-000695 · form4-01092023_050101.xml · derivative · entry 3 Rosen Joshua · CIK 0001880089 · Director · INTERIM PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,453 Underlying: Subordinate Voting Shares · 79,468 shares Expires 2032-12-14 Read SEC document |
| December 14, 2022 Filed Jan 9, 2023 17:05 UTC | Vireo Growth Inc. GDNSF · Entity 5397 | GrantRestricted Stock Units | 66,272 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-000695 · form4-01092023_050101.xml · nonDerivative · entry 1 Rosen Joshua · CIK 0001880089 · Director · INTERIM PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,857 Read SEC document |
| March 15, 2022 Filed Mar 18, 2022 14:39 UTC | Vireo Growth Inc. GDNSF · Entity 5397 | GrantStock Options · Derivative | 39,985 | $0.00 Strike: $1.77 | $0.00 |
DisclosureSEC source: 0001415889-22-003178 · form4-03182022_110337.xml · derivative · entry 2 Rosen Joshua · CIK 0001880089 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,985 Underlying: Subordinate Voting Shares · 39,985 shares Expires 2032-03-14 F2 · derivative.exercise_date: Stock Options vest in full on March 31, 2023. Read SEC document |
| March 15, 2022 Filed Mar 18, 2022 14:39 UTC | Vireo Growth Inc. GDNSF · Entity 5397 | GrantRestricted Stock Units | 16,585 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-003178 · form4-03182022_110337.xml · nonDerivative · entry 1 Rosen Joshua · CIK 0001880089 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,585 F1 · shares: Restricted Stock Units vest in three equal annual installments beginning on March 31, 2023; each vested tranche becomes Subordinated Voting Shares. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.